Collaborative Stage Data Set - Revised 8/7/2013
Vulva
Vulva (including Skin of Vulva) (excluding Malignant Melanoma, Merkel Cell Carcinoma, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease, and Other Lymphomas)
C51.0-C51.2, C51.8-C51.9
- DISCONTINUED SITE-SPECIFIC FACTORS: SSF12, SSF13, SSF14, SSF15
- C51.0 Labium majus
- C51.1 Labium minus
- C51.2 Clitoris
- C51.8 Overlapping lesion of vulva
- C51.9 Vulva, NOS
- Note 1: This schema includes skin of Vulva but is NOT used for Malignant Melanoma, Merkel Cell Carcinoma, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease, or Other Lymphomas. Each of these diseases has a separate schema.
- Note 2: Involvement of the vulva and perineum should be assigned to vulva as the primary site in the absence of a statement that the tumor extended from the perineum to the vulva. Collaborative Stage only includes C51.0-C51.9 (vulva) and does not include primaries of the perineum in this schema. Basal and squamous cell carcinomas of the skin of the vulva are coded to C51.9 and are reportable; basal and squamous carcinomas of the skin of the perineum would be coded to C44.5 and would not be reportable.
- Note 3: AJCC TNM values correspond to the stages accepted by the Federation Internationale de Gynecologic et d'Obstetrique (FIGO). Note that FIGO uses a single stage value which corresponds to different groupings of T, N, and M values.